Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.
Modulo Bio has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Modulo Bio's investors include Initialized Capital, Builders VC, Refactor, Cantos, Spacecadet Ventures.
Modulo Bio is headquartered in San Diego, United States.
Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.
Modulo Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modulo Bio — Funding & Investors." VCBacked, March 19, 2025, https://www.vcbacked.co/company/modulo-bio. Accessed July 22, 2026.
VCBacked. (2025). Modulo Bio — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/modulo-bio
{{cite web |title=Modulo Bio — Funding & Investors |url=https://www.vcbacked.co/company/modulo-bio |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated